Cargando…

Pembrolizumab in a Patient With a Metastatic CASTLE Tumor of the Parotid

Carcinoma showing thymus-like elements (CASTLE) is a rare tumor, most commonly found in the thyroid gland. Here we report a case of CASTLE tumor localized to the parotid gland, recognized in retrospect after a late manifestation of symptomatic pleural carcinomatosis. The original tumor in the paroti...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lorenz, Lisa, von Rappard, Joscha, Arnold, Walter, Mutter, Nicole, Schirp, Udo, Scherr, Andreas, Jehle, Andreas Werner
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2019
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6702522/ https://www.ncbi.nlm.nih.gov/pubmed/31475102 http://dx.doi.org/10.3389/fonc.2019.00734

Ejemplares similares

CASTLE Thyroid Tumor: A Case Report and Literature Review
por: Lominska, Chris, et al.
Publicado: (2017)

The castle
por: Kafka, Franz, 1883-1924
Publicado: (1957)

Breaching the Castle Walls: Hyaluronan Depletion as a Therapeutic Approach to Cancer Therapy
por: Shepard, H. Michael
Publicado: (2015)

The Castle of Indolence
por: Thomson, James
Publicado: (1921)

Pembrolizumab Plus Chemotherapy in Metastatic Thymic Carcinoma: A Case Report
por: Thomas, Quentin Dominique, et al.
Publicado: (2022)

Response of Metastatic Chordoma to the Immune Checkpoint Inhibitor Pembrolizumab: A Case Report
por: Wu, Xiaoli, et al.
Publicado: (2020)

Phase I trial of pembrolizumab plus vemurafenib and cobimetinib in patients with metastatic melanoma
por: Shaikh, Saba S., et al.
Publicado: (2022)

Case Report: Prolonged remission of metastatic cisplatin-refractory nasopharyngeal carcinoma with Pembrolizumab
por: Wang, Wei Cen, et al.
Publicado: (2023)

The castle of crossed destinies /
por: Calvino, Italo
Publicado: (1976)

Management and Prognostic Factors for Thyroid Carcinoma Showing Thymus-Like Elements (CASTLE): A Case Series Study
por: Gao, Rui, et al.
Publicado: (2018)

The Three P's: Parotid, PD-L1, and Pembrolizumab
por: Wiggins, Amanda, et al.
Publicado: (2019)

Pembrolizumab-Induced Psoriasis in Metastatic Melanoma: Activity and Safety of Apremilast, a Case Report
por: Siciliano, Maria Anna, et al.
Publicado: (2020)

Case report: Treatment of metastatic dedifferentiated chondrosarcoma with pembrolizumab yields sustained complete response
por: Singh, Amisha, et al.
Publicado: (2022)

Prehistoric villages, castles, and towers of southwestern Colorado /
por: Fewkes, Jesse Walter, 1850-1930
Publicado: (1919)

Ex Vivo Drug Screening Informed Targeted Therapy for Metastatic Parotid Squamous Cell Carcinoma
por: Nykänen, Noora, et al.
Publicado: (2021)

Extensive intramuscular manifestation of sarcoidosis with initially missed diagnosis and delayed therapy: a case report
por: Meyer, Niklaus, et al.
Publicado: (2017)

Rescue of Immunotherapy-Refractory Metastatic Merkel Cell Carcinoma With Conventionally Fractionated Radiotherapy and Concurrent Pembrolizumab
por: Bloom, Brooke C., et al.
Publicado: (2019)

Wilton Park - Castle of Lucens
por: Brice, Maximilien
Publicado: (2015)

Collections of the royal castle of Wawel
Publicado: (1969)

Mozart concert in Tarascon Castle
Publicado: (1982)

Nightmare abbey crotchet castle
por: Peacock, Thomas Love, 1785-1866

Dr. Frederick A. Castle
Publicado: (1902)

An attention base U-net for parotid tumor autosegmentation
por: Xia, Xianwu, et al.
Publicado: (2022)

Studying the Developing Brain in Real-World Contexts: Moving From Castles in the Air to Castles on the Ground
por: Wass, Sam V., et al.
Publicado: (2022)

ESF-EMBO Symposium “Molecular Biology and Innovative Therapies in Sarcomas of Childhood and Adolescence” Sept 29–Oct 4, Polonia Castle Pultusk, Poland
por: Schäfer, Beat W., et al.
Publicado: (2013)

Simultaneous pembrolizumab-induced myasthenia gravis and myocarditis in a patient with metastatic bladder cancer: A case report
por: Takai, Manabu, et al.
Publicado: (2020)

Pembrolizumab-combination therapy for previously untreated metastatic nonsquamous NSCLC: Real-world outcomes at US oncology practices
por: Liu, Stephen V., et al.
Publicado: (2022)

Clinical significance of hyperbilirubinemia in the CASTLE study
por: Uy, J, et al.
Publicado: (2010)

Aerial view of Collex-Bossy's castle.
por: Jean-Luc Caron
Publicado: (1996)

Dublin Castle and the Royal College of Surgeons
Publicado: (1921)

Letter from New Castle, Ky.
por: Culver, C. P.
Publicado: (1853)

New Castle (Ind.) Medical Society
por: Acestor, Vindex
Publicado: (1857)

Pembrolizumab Plus Chemotherapy or Anlotinib vs. Pembrolizumab Alone in Patients With Previously Treated EGFR-Mutant NSCLC
por: Chen, Ya, et al.
Publicado: (2021)

Case Report: Two Cases of Chemotherapy Refractory Metastatic Penile Squamous Cell Carcinoma With Extreme Durable Response to Pembrolizumab
por: Chahoud, Jad, et al.
Publicado: (2020)

Case Report: Toripalimab Combined With Anlotinib in a Patient With Metastatic Upper Tract Urothelial Carcinoma After Pembrolizumab Failure
por: Zan, Ning, et al.
Publicado: (2022)

Metastatic Liposarcoma to the Parotid
por: Trabelsi, Amel, et al.
Publicado: (2008)

Epidemic Metastatic Parotiditis
por: Miller, Charles H.
Publicado: (1881)

Case Report: Complete Response of Recurrent and Metastatic Cystadenocarcinoma of the Parotid Gland With a Single Course of Combined Nivolumab and Ipilimumab Therapy
por: Nakamura, Yoshiyuki, et al.
Publicado: (2021)

Contouring the accessory parotid gland and major parotid glands as a single organ at risk during nasopharyngeal carcinoma radiotherapy
por: Cai, Xin-Ling, et al.
Publicado: (2022)

Case Report: Partial response to single-agent pembrolizumab in a chemotherapy-resistant metastatic pancreatic cancer patient with a high tumor mutation burden
por: Dai, Mengyao, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_f52fr4uokfoqp38a2lckr1r7no